COMPOSITIONS AND METHODS FOR ACTIVE SURVEILLANCE OF PROSTATE CANCER.

• 1. 用于主动监控前列腺癌的组合物和方法 [P] . 中国专利： CN107530412A . 2018-01-02
• 2. 用于预防前列腺癌或减缓前列腺癌发展的组合物 [P] . 中国专利： CN102112141B . 2013.03.06
• 3. Compositions and Methods for Active monitoring of Prostate Cancer. [P] . CL2017002701A1 . 2018-07-06

  机译： 主动监测前列腺癌的成分和方法。

• 4. METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF SCREENING FOR MODULATORS OF PROSTATE CANCER. [P] . MXPA03003151A . 2003-08-19

  机译： 前列腺癌的诊断方法，前列腺癌调节剂的组成和筛选方法。

• 5. Compositions and Methods for Active Surveillance for Prostate Cancer [P] . PE9302018A1 . 2018-06-08

  机译： 前列腺癌主动监测的组成和方法

• 1. Tools to identify the men with prostate cancer most appropriate for active surveillance? [J] . Robert H Getzenberg 亚洲男性学杂志（英文版） . 2014,第001期
• 2. PSA-based prostate cancer screening： the role of active surveillance and informed and shared decision making [J] . Lionne D F Venderbos, Monique J Roobol 亚洲男性学杂志：英文版 . 2011,第002期
• 3. Outcome following active surveillance of men with screen-detected prostate cancer. Results from the g?teborg randomised population-based prostate cancer screening trial [J] . GodtmanR.A., HolmbergE., KhatamiA., European urology . 2013,第1期
• 4. Re: Outcome following active surveillance of men with screen-detected prostate cancer. Results from the G?teborg randomised population-based prostate cancer screening trial [J] . TanejaS.S. The Journal of Urology . 2013,第1期
• 5. Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. [J] . Adamy A, Yee DS, Matsushita K, The Journal of Urology . 2011,第2期
• 6. The Emerging Role of Biomarkers to Improve Active Surveillance for Low-Risk Prostate Cancer [C] . Matthew R. Cooperberg Genitourinary Cancers Symposium . 2013
• 7. The accuracy of prostate biopsy to assign patients with low-grade prostate cancer to active surveillance. [D] . Ghleilib, Intisar. 2014
• 8. Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods [O] . Steven Canfield, Michael J. Kemeter, John Hornberger, 2017
• 9. Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer. [O] . Loeb, Stacy, Folkvaljon, Yasin, Makarov, Danil V, 2015
• 10. RTVP Based Compositions and Methods for the Treatment of Prostate Cancer. [R] . Thompson, T. C., Ren, C. 2005

• 1. Expending the Paradigm: Active Surveillance for Intermediate Risk Prostate Cancer [J] . Mohamed Jalloh ,Mamadou Tieoule Traore ,Thierno Amadou Diallo . 泌尿学期刊（英文） . 2018,第8期
• 2. Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance [J] . Larissa J Vos ,Michele Janoski ,Keith Wachowicz . 世界放射学杂志：英文版（电子版） . 2016,第4期
• 3. Bioinformatic analysis reveals novel biomarkers and candidate drug compositions in prostate cancer [J] . Yi-Dan Sun ,Ying Zhang ,Shi-Qi Ren . TMR整合医学 . 2020,第004期
• 4. DCS、PLC系统中用于监视和测量的计算机软件确认方法的探讨和实践 [C] . 谢海金 . 第七届中国石油和化工自动化技术年会 . 2008
• 5. 癌旁组织标志物用于早期诊断前列腺癌的初步研究 [A] . 刘通 . 2017